Importance Based on contemporary estimates in the US, evidence-based therapies for
cardiovascular risk reduction are generally underused among patients with type 2 diabetes …

Importance Evidence-based therapies to reduce atherosclerotic cardiovascular disease risk
in adults with type 2 diabetes are underused in clinical practice. Objective To assess the …

Background Evidence‐based therapies are generally underused for cardiovascular risk
reduction; however, less is known about contemporary patients with type 2 diabetes mellitus …

In summary, in a large contemporary US cohort of patients with diabetes mellitus and
ASCVD, few patients received comprehensive guideline–recommended medical therapies …

Evidence‐based therapy that target hyperlipidemia, hypertension, smoking cessation, and
weight loss have demonstrated significant benefits in reducing cardiovascular risks and …

Lipid-lowering therapies and cardiovascular risk-stratificat... : Current Opinion in
Endocrinology, Diabetes and Obesity Lipid-lowering therapies and cardiovascular risk-stratification …

Aim To examine improvement in the use of optimal medical therapy (OMT) for secondary
prevention in patients with atherosclerotic cardiovascular disease (ASCVD) and diabetes …

BACKGROUND: Type 2 diabetes mellitus (T2DM) is a chronic condition with a high
economic burden as well as drug treatments that have not all demonstrated effects on …

Background Cardiovascular disease remains the primary source of morbidity and mortality
in type 2 diabetes (T2D). We characterized the change over time in the use of evidence …

Objectives The purpose of this study was to assess atherosclerotic cardiovascular disease
(ASCVD) prevalence, antidiabetes medication usage and physician specialty encounters …